SCRIPTGEN Trademark
Trademark Overview
On Monday, November 14, 1994, a trademark application was filed for SCRIPTGEN with the United States Patent and Trademark Office. The USPTO has given the SCRIPTGEN trademark a serial number of 74599005. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, September 4, 1999. This trademark is owned by SCRIPTECH PHARMACEUTICAL, INC.. The SCRIPTGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations for the treatment of infectious diseases including, but not limited to bacterial, fungal, and viral infections; peripheral or central nervous system diseases including, but not limited to schizophrenia, depression, alzheimers, migraines, anxiety, and pain; cardiovascular system diseases including, but not limited to atherosclerosis, hypertension, stroke, and congestive heart failure; digestive organs diseases including, but not limited to gastric ulcers, and esophagal reflux; musculosketal system diseases including, but not limited to arthritis; metabolic diseases including, but not limited to obesity and diabetes; respiratory system diseases including, but not limited to asthma, pneumonia, and tuberculosis; urogenital organs diseases including, but not limited to cystitis, yeast infections, and hepatitis; neoplastic diseases including, but not limited to cancer of the breast, lung, prostate, and colon; skin disorders including, but not limited to psoriasis ...
research services in the field of biology and medicine
General Information
Serial Number | 74599005 |
Word Mark | SCRIPTGEN |
Filing Date | Monday, November 14, 1994 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Saturday, September 4, 1999 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, June 11, 1996 |
Trademark Statements
Goods and Services | pharmaceutical preparations for the treatment of infectious diseases including, but not limited to bacterial, fungal, and viral infections; peripheral or central nervous system diseases including, but not limited to schizophrenia, depression, alzheimers, migraines, anxiety, and pain; cardiovascular system diseases including, but not limited to atherosclerosis, hypertension, stroke, and congestive heart failure; digestive organs diseases including, but not limited to gastric ulcers, and esophagal reflux; musculosketal system diseases including, but not limited to arthritis; metabolic diseases including, but not limited to obesity and diabetes; respiratory system diseases including, but not limited to asthma, pneumonia, and tuberculosis; urogenital organs diseases including, but not limited to cystitis, yeast infections, and hepatitis; neoplastic diseases including, but not limited to cancer of the breast, lung, prostate, and colon; skin disorders including, but not limited to psoriasis and herpes; immune system diseases including, but not limited to HIV, rheumatoid arthritis, and immune suppression agents for organ transplants; hematopoietic diseases including, but not limited to sickle cell anemia, thalassemia, hemostasis and other blood disorders; genetic diseases including, but not limited to down's syndrome, Huntington's chorea, and cystic fibrosis; endocrine system diseases including, but not limited to symptoms of menopause; reproductive system diseases including, but not limited to fertility control |
Goods and Services | research services in the field of biology and medicine |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 3, 1995 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 3, 1995 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | SCRIPTGEN PHARMACEUTICALS, INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | MEDFORD, MA 02155 |
Party Name | SCRIPTGEN PHARMACEUTICALS, INC. |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | MEDFORD, MA 02155 |
Party Name | SCRIPTECH PHARMACEUTICAL, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Medford, MA 02155 |
Trademark Events
Event Date | Event Description |
Friday, January 21, 2000 | ABANDONMENT - NO USE STATEMENT FILED |
Monday, March 8, 1999 | EXTENSION 5 GRANTED |
Tuesday, February 16, 1999 | EXTENSION 5 FILED |
Tuesday, September 22, 1998 | EXTENSION 4 GRANTED |
Wednesday, September 2, 1998 | EXTENSION 4 FILED |
Monday, April 13, 1998 | EXTENSION 3 GRANTED |
Tuesday, March 3, 1998 | EXTENSION 3 FILED |
Sunday, June 1, 1997 | EXTENSION 2 GRANTED |
Tuesday, May 13, 1997 | EXTENSION 2 FILED |
Wednesday, April 2, 1997 | EXTENSION 1 GRANTED |
Friday, February 28, 1997 | EXTENSION 1 FILED |
Tuesday, September 3, 1996 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, June 11, 1996 | PUBLISHED FOR OPPOSITION |
Friday, May 10, 1996 | NOTICE OF PUBLICATION |
Thursday, March 21, 1996 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, March 12, 1996 | REINSTATED |
Thursday, December 14, 1995 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, April 26, 1995 | NON-FINAL ACTION MAILED |
Wednesday, March 29, 1995 | ASSIGNED TO EXAMINER |